Laboratory Co. of America (NYSE:LH) Issues FY 2025 Earnings Guidance

Laboratory Co. of America (NYSE:LH) issued an update on its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 15.600-16.400 for the period, compared to the consensus estimate of 15.990. The company issued revenue guidance of $13.9 billion-$14.1 billion, compared to the consensus revenue estimate of $13.8 billion.

Analyst Ratings Changes

A number of equities analysts recently commented on LH shares. HSBC upgraded shares of Laboratory Co. of America from a “hold” rating to a “buy” rating in a research note on Wednesday, October 30th. Morgan Stanley increased their price objective on Laboratory Co. of America from $260.00 to $270.00 and gave the company an “overweight” rating in a report on Tuesday, December 17th. Evercore ISI raised Laboratory Co. of America from an “in-line” rating to an “outperform” rating and raised their target price for the stock from $260.00 to $265.00 in a research report on Tuesday, January 7th. Jefferies Financial Group reiterated a “buy” rating and issued a $275.00 price target (up from $265.00) on shares of Laboratory Co. of America in a research note on Tuesday, December 10th. Finally, Robert W. Baird raised their price objective on shares of Laboratory Co. of America from $282.00 to $289.00 and gave the stock an “outperform” rating in a report on Friday, October 25th. Four analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Laboratory Co. of America currently has a consensus rating of “Moderate Buy” and a consensus target price of $263.46.

Laboratory Co. of America Stock Performance

NYSE LH opened at $250.01 on Thursday. The stock has a market capitalization of $20.91 billion, a price-to-earnings ratio of 48.36, a PEG ratio of 1.86 and a beta of 1.07. The business’s 50 day moving average is $236.30 and its two-hundred day moving average is $229.20. Laboratory Co. of America has a 12-month low of $191.97 and a 12-month high of $258.59. The company has a current ratio of 1.44, a quick ratio of 1.30 and a debt-to-equity ratio of 0.66.

Laboratory Co. of America (NYSE:LH) last released its earnings results on Thursday, February 6th. The medical research company reported $3.45 EPS for the quarter, beating analysts’ consensus estimates of $3.40 by $0.05. Laboratory Co. of America had a return on equity of 15.27% and a net margin of 3.43%. Research analysts expect that Laboratory Co. of America will post 14.51 EPS for the current year.

Laboratory Co. of America Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 12th. Stockholders of record on Thursday, February 27th will be given a dividend of $0.72 per share. The ex-dividend date is Thursday, February 27th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 1.15%. Laboratory Co. of America’s payout ratio is 55.71%.

Insider Buying and Selling

In other news, EVP Glenn A. Eisenberg sold 11,711 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $240.43, for a total value of $2,815,675.73. Following the sale, the executive vice president now directly owns 31,289 shares in the company, valued at $7,522,814.27. This represents a 27.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Kerrii B. Anderson sold 1,000 shares of Laboratory Co. of America stock in a transaction that occurred on Tuesday, January 7th. The stock was sold at an average price of $235.00, for a total value of $235,000.00. Following the transaction, the director now owns 12,722 shares of the company’s stock, valued at $2,989,670. This represents a 7.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 24,572 shares of company stock worth $5,915,209 in the last quarter. Company insiders own 0.85% of the company’s stock.

About Laboratory Co. of America

Labcorp Holdings, Inc engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.